Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations

被引:30
作者
Al-Mulla, F
MacKenzie, EM
机构
[1] Kuwait Univ, Fac Med, Dept Pathol, Mol Pathol Lab, Safat 13110, Kuwait
[2] Beatson Inst Canc Res, CRC, Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
关键词
Ras; Ras mutants; in vitro invasion; signal transduction; aggression;
D O I
10.1002/path.995
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p21 proteins encoded by N-, Ki-, and H-ras are small guanine nucleotide-binding proteins that act as switches in several signal transduction pathways. Recently, evidence has been accumulating to suggest that valine-12 mutation in the Ki-Ras protein is associated with lung and colorectal tumours that are more aggressive than those carrying aspartate-12 mutation. The purpose of this study was to determine whether cells transfected with different Ki-ras codon-12 mutants have different biological behaviours in vitro that could reflect the differences in behaviour in vivo. For that reason, Rat-1 fibroblasts transfected with the valine-12 or aspartate-12 mutant or the wild-type Ki-ras gene were assessed in terms of in vitro invasion, transformation, and VEGF production. Both mutants demonstrated equal abilities to transform Rat-1 cells and induce VEGF production, while cells transfected with wild-type Ki-Ras failed to do so. Most significantly, the valine-12 mutants demonstrated a greater ability to invade Matrigel than cells expressing the aspartate-12 mutant or wild-type Ki-Ras proteins. This study complements previous experimental data that specific Ras mutations differ in their effects in vivo and shows, for the first time, a significant difference in Matrigel invasion in vitro. The precise mechanisms behind these biological differences in vivo and in vitro should now be investigated. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:549 / 556
页数:8
相关论文
共 42 条
  • [1] Al-Mulla F, 1998, J PATHOL, V185, P130, DOI 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO
  • [2] 2-M
  • [3] Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study
    Andreyev, HJN
    Norman, AR
    Cunningham, D
    Oates, JR
    Clarke, PA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) : 675 - 684
  • [4] TRANSFORMATION OF HUMAN BREAST EPITHELIAL-CELLS BY C-HA-RAS ONCOGENE
    BASOLO, F
    ELLIOTT, J
    TAIT, L
    CHEN, XQ
    MALONEY, T
    RUSSO, IH
    PAULEY, R
    MOMIKI, S
    CAAMANO, J
    KLEINSZANTO, AJP
    KOSZALKA, M
    RUSSO, J
    [J]. MOLECULAR CARCINOGENESIS, 1991, 4 (01) : 25 - 35
  • [5] PROGNOSTIC-SIGNIFICANCE OF K-RAS MUTATIONS IN COLORECTAL-CARCINOMA
    BENHATTAR, J
    LOSI, L
    CHAUBERT, P
    GIVEL, JC
    COSTA, J
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : 1044 - 1048
  • [6] BONDY GP, 1985, CANCER RES, V45, P6005
  • [7] BOS JL, 1989, CANCER RES, V49, P4682
  • [8] NEOPLASTIC PROGRESSION OF HUMAN AND RAT INTESTINAL-CELL LINES AFTER TRANSFER OF THE RAS AND POLYOMA MIDDLE T-ONCOGENES
    CHASTRE, E
    EMPEREUR, S
    DIGIOIA, Y
    ELMAHDANI, N
    MAREEL, M
    VLEMINCKX, K
    VANROY, F
    BEX, V
    EMAMI, S
    SPANDIDOS, DA
    GESPACH, C
    [J]. GASTROENTEROLOGY, 1993, 105 (06) : 1776 - 1789
  • [9] Matrix metalloproteinases and the development of cancer
    Coussens, LM
    Werb, Z
    [J]. CHEMISTRY & BIOLOGY, 1996, 3 (11): : 895 - 904
  • [10] Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling
    Denhardt, DT
    [J]. BIOCHEMICAL JOURNAL, 1996, 318 : 729 - 747